ロード中...
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation
The curative potential of MHC-matched allogeneic bone marrow transplantation (BMT) is in part because of immunologic graft-versus-tumor (GvT) reactions mediated by donor T cells that recognize host minor histocompatibility antigens. Immunization with leukemia-associated antigens, such as Wilms Tumor...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3217412/ https://ncbi.nlm.nih.gov/pubmed/21868578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-05-356238 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|